Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
Related Posts
Zhang Q, Hutchison ER, Pan C, Warren MF, Keller MP, Attie AD, Lusis AJ, Rey FE. Systems genetics uncovers associations among host amylase locus, gut[...]
Maqsood MH, Zhang RS, Rosenfeld K, Moriarty JM, Rosovsky RP, Horowitz JM, Alviar CL, Bangalore S. Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism[...]
Rosa WE, Connor S, Aggarwal G, Alsirafy S, Brennan J, Davies H, Downing J, Ferrell B, Harding R, Knaul FM, Luyirika EBK, Marroquín MM, Marston[...]